In a significant market development, Nestlé India and Dr. Reddy's Laboratories established a joint venture focused on bringing innovative nutraceutical brands to consumers in India and other agreed territories. The strategic partnership aims to combine Nestlé Health Science's global range of nutritional health solutions with Dr. Reddy's strong commercial capabilities...
India Rises on Global Economic Stage: Report
With a population of 1.4 billion, India has surpassed China and is now the fifth-largest economy as also the largest democracy in the world. The median age of the population is 27.6. This year, 642 million citizens cast their vote in the country's general elections and a new national government...
Aurigene Pharmaceutical to Invest in India’s Genome Valley
Aurigene Discovery Technologies Limited, a research, development, and manufacturing services organization and subsidiary of Dr. Reddy's Laboratories, announced plans to construct a development and manufacturing facility for therapeutic proteins, antibodies, and viral vectors in Genome Valley at Hyderabad, India. As the first phase of investment, Aurigene will invest $40 million...
Dr. Reddy’s Partners with Olema Pharma
San Francisco-based Olema and Aurigene Discovery Technologies, a wholly-owned unit of Dr. Reddy's Laboratories of Hyderabad, India have inked an exclusive global license agreement to research, develop, and commercialize novel small molecule inhibitors of an undisclosed oncology target. Under the terms of the agreement, Olema will make an upfront licensing...
Novartis’ Cardiac Drug to Go Off-Patent in January
Swiss-American multinational pharmaceutical, Novartis AG's drug Vymada or Entresto used for patients with heart failure becomes off-patent in January, 2023 Heart failure is a progressive chronic syndrome characterized by a decrease in the functions of the heart and quality of life. 23 million people are affected by it worldwide, while...
Merck Licenses New Covid Treatment to 5 Indian Companies
Merck has inked pacts with multiple Indian companies: Cipla, Dr Reddy's Laboratories, Sun Pharma, Hetero Labs, and Emcure Pharmaceuticals to license and produce a forthcoming treatment for Covid-19. The company, formally known as MSD, is in the process of developing molnupiravir in collaboration with Ridgeback Biotherapeutics. The investigational oral antiviral...